Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK "needs better oesophageal cancer diagnostics"

This article was originally published in Clinica

Executive Summary

Research into better diagnostics for oesophageal cancer is needed in the UK to address a significant increase in incidence of the disease, the government's chief adviser has warned. In his 2007 annual report as chief medical officer for England, published yesterday, Sir Liam Donaldson reports that the UK has some of the highest rates of the disease in Europe. Contrary to sharp decreases in some European countries, such as France, he notes, the disease has risen by 86% in men and 40% in women over the last 20 years in the UK, making it the sixth most common cause of cancer death. Some 6,000 people die annually from the disease in England and Wales.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042024

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel